0
Skip to Content
Gadolinium 64
Letters
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
About Gd
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
History of Harm
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Media
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Patients
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Physicians
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Support Us
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report
Gadolinium 64
Letters
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
About Gd
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
History of Harm
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Media
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Patients
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Physicians
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Support Us
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report
Folder: Letters
Back
Letter to RFK Jr.
2020 Letter to FDA
2012 Letter to FDA
Folder: About Gd
Back
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Advocacy
Folder: History of Harm
Back
Timeline
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
GBCA Forms
Folder: Media
Back
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Folder: Patients
Back
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Folder: Physicians
Back
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Folder: Support Us
Back
Goals
Donate
Contact Us
Sign the Petition
Make FDA Report

Categories: All Articles • Nanoparticles • Dechelation • Cellular + Mito Dysfunction • GDD/Toxicity • Fibrosis • Other Disease • Chemistry • Heavy Metal Toxicity • Treatment Options • Water Contamination • Other Gd Uses • Pediatrics • Chelators

Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution (June 2020).
Bridget Belo 6/1/20 Bridget Belo 6/1/20

Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution (June 2020).

Read More
Anthropogenic gadolinium in freshwater and drinking water systems
Water Contamination, Chemistry Bridget Belo 5/29/20 Water Contamination, Chemistry Bridget Belo 5/29/20

Anthropogenic gadolinium in freshwater and drinking water systems

Read More
Evaluation of toxicity of gadolinium-based contrast agents on neuronal cells (May 2020).
Bridget Belo 5/4/20 Bridget Belo 5/4/20

Evaluation of toxicity of gadolinium-based contrast agents on neuronal cells (May 2020).

Read More
Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases (Feb 2020).
Cellular/Mitochondria dysfunction, Other Disease, Treatment Options Bridget Belo 2/19/20 Cellular/Mitochondria dysfunction, Other Disease, Treatment Options Bridget Belo 2/19/20

Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases (Feb 2020).

Read More
Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation (Jan 2020).
Pediatric Bridget Belo 1/27/20 Pediatric Bridget Belo 1/27/20

Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation (Jan 2020).

Read More
Physicochemical and Pharmacokinetic Profiles of Gadopiclenol A New Macrocyclic Gadolinium Chelate With High T1 Relaxivity (Aug 2019).
Bridget Belo 8/1/19 Bridget Belo 8/1/19

Physicochemical and Pharmacokinetic Profiles of Gadopiclenol A New Macrocyclic Gadolinium Chelate With High T1 Relaxivity (Aug 2019).

Read More
Gadolinium-Based MRI Contrast Agents Induce Mitochondrial Toxicity and Cell Death in Human Neurons, and Toxicity Increases With Reduced Kinetic Stability of the Agent (2019).
Bridget Belo 8/1/19 Bridget Belo 8/1/19

Gadolinium-Based MRI Contrast Agents Induce Mitochondrial Toxicity and Cell Death in Human Neurons, and Toxicity Increases With Reduced Kinetic Stability of the Agent (2019).

Read More
Heavy metal toxicity: An update of chelating therapeutic strategies
General Chemistry Bridget Belo 7/1/19 General Chemistry Bridget Belo 7/1/19

Heavy metal toxicity: An update of chelating therapeutic strategies

Read More
Molecular neurochemistry of the lanthanides (2019).
Bridget Belo 6/6/19 Bridget Belo 6/6/19

Molecular neurochemistry of the lanthanides (2019).

Read More
An Initiative to Reduce Unnecessary Gadolinium-Based Contrast in Multiple Sclerosis Patients (Sept 2019).
Kate 5/16/19 Kate 5/16/19

An Initiative to Reduce Unnecessary Gadolinium-Based Contrast in Multiple Sclerosis Patients (Sept 2019).

Read More
Heavy metal toxicity: An update of chelating therapeutic strategies (July 2019).
Treatment Options, Chelators, Heavy Metal Toxicity, Chemistry Bridget Belo 5/15/19 Treatment Options, Chelators, Heavy Metal Toxicity, Chemistry Bridget Belo 5/15/19

Heavy metal toxicity: An update of chelating therapeutic strategies (July 2019).

Read More
A Structured Survey on Adverse Events Occurring Within 24 Hours After Intravenous Exposure to Gadodiamide or Gadoterate Meglumine: A Controlled Prospective Comparison Study (2019).
Bridget Belo 4/1/19 Bridget Belo 4/1/19

A Structured Survey on Adverse Events Occurring Within 24 Hours After Intravenous Exposure to Gadodiamide or Gadoterate Meglumine: A Controlled Prospective Comparison Study (2019).

Read More
Use of gadolinium contrast agents in paediatric [pediatric] population: Donald Rumsfeld meets Hippocrates! (Feb 2019).
Pediatric Bridget Belo 2/7/19 Pediatric Bridget Belo 2/7/19

Use of gadolinium contrast agents in paediatric [pediatric] population: Donald Rumsfeld meets Hippocrates! (Feb 2019).

Read More
Gadolinium as an Emerging Microcontaminant in Water Resources: Threats and Opportunities (2019).
Water Contamination Kate 1/4/19 Water Contamination Kate 1/4/19

Gadolinium as an Emerging Microcontaminant in Water Resources: Threats and Opportunities (2019).

Read More
Urinary Gadolinium Levels After Contrast-Enhanced MRI in Individuals with Normal Renal Function: a Pilot Study (2018).
Kate 12/12/18 Kate 12/12/18

Urinary Gadolinium Levels After Contrast-Enhanced MRI in Individuals with Normal Renal Function: a Pilot Study (2018).

Read More
Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives (2018).
Kate 9/20/18 Kate 9/20/18

Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives (2018).

Read More
Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates (Sept 2018).
Bridget Belo 9/11/18 Bridget Belo 9/11/18

Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates (Sept 2018).

Read More
Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents (Mar 2018).
Chelators, Treatment Options, Heavy Metal Toxicity, Chemistry, GDD/Toxicity Bridget Belo 3/13/18 Chelators, Treatment Options, Heavy Metal Toxicity, Chemistry, GDD/Toxicity Bridget Belo 3/13/18

Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents (Mar 2018).

Read More
Newer Posts
Older Posts

Submit any resources that should be included on the site.

Explore Gadolinium 64

Physicians

Donate

This site is also accessible via contrastdie.com
 
Fair Use Disclaimer
This website features copyrighted material used in accordance with the principles of fair use as outlined in Section 107 of the U.S. Copyright Act. The material is provided to inform, educate, and encourage public discussion on important issues, including health, education, and science. All content is shared with the intent of advancing understanding and fostering meaningful dialogue. This use is non-commercial and aligns with fair use standards for purposes such as research, education, and commentary. If you believe any content on this site infringes on your copyright, please contact us at Contact Us and we will review your concerns promptly.